A pooled analysis compared survival among patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy and either targeted therapy or immunotherapy regimens utilizing checkpoint inhibitors.
Kevin Wright
Advertisement
Articles by Kevin Wright
Advertisement
Latest Updated Articles
Cytoreductive Nephrectomy, Immunotherapy-Based Systemic Therapy Induce Benefit in mRCCPublished: December 3rd 2020 | Updated:
Advertisement
Advertisement
